甲基化CpG结合域蛋白2通过协调成纤维细胞向肌成纤维细胞分化促进肺纤维化
在IPF患者肺组织和博来霉素诱导的小鼠肺纤维化模型中,DNA甲基化改变伴随肌成纤维细胞中MBD2过表达。成纤维细胞或肌成纤维细胞中敲除Mbd2可保护小鼠免受博来霉素诱导的肺纤维化并显著减少成纤维细胞分化。TGF-β1通过TβRI/Smad3诱导Mbd2过表达,Mbd2结合Erdr1启动子甲基化CpG DNA抑制其表达,增强TGF-β/Smad信号促进分化;增强Erdr1表达可逆转已建立的肺纤维化。
要点
- IPF患者和小鼠肺纤维化中肌成纤维细胞MBD2过表达。
- 成纤维细胞/肌成纤维细胞敲除Mbd2可减轻博来霉素诱导的肺纤维化。
- 增强Erdr1表达可逆转已建立的肺纤维化。
核心结论
- 沉默Mbd2或增加Erdr1可能是肺纤维化预防和治疗的可行策略。
研究设计与样本
- 研究纳入IPF患者肺组织和博来霉素诱导的小鼠肺纤维化模型,并在成纤维细胞或肌成纤维细胞中敲除Mbd2。
主要发现
- IPF患者和博来霉素诱导的小鼠肺纤维化中DNA甲基化改变,肌成纤维细胞MBD2过表达。
- 成纤维细胞或肌成纤维细胞中敲除Mbd2可保护小鼠免受博来霉素诱导的肺纤维化,并显著减少成纤维细胞分化。
- TGF-β1通过TβRI/Smad3诱导成纤维细胞全局DNA高甲基化和Mbd2过表达。
- Mbd2选择性结合Erdr1启动子甲基化CpG DNA抑制其表达,增强TGF-β/Smad信号促进成纤维细胞向肌成纤维细胞分化。
- 增强Erdr1表达可显著逆转已建立的肺纤维化。
临床怎么用
- 针对Mbd2或Erdr1的干预策略可能用于肺纤维化的预防和治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although DNA methylation has been recognised in the pathogenesis of idiopathic pulmonary fibrosis (IPF), the exact mechanisms are yet to be fully addressed. Herein, we demonstrate that lungs originated from IPF patients and mice after bleomycin (BLM)-induced pulmonary fibrosis are characterised by altered DNA methylation along with overexpression in myofibroblasts of methyl-CpG-binding domain 2 (MBD2), a reader responsible for interpreting DNA methylome-encoded information. Specifically, depletion of Mbd2 in fibroblasts or myofibroblasts protected mice from BLM-induced pulmonary fibrosis coupled with a significant reduction of fibroblast differentiation. Mechanistically, transforming growth factor (TGF)-β1 induced a positive feedback regulatory loop between TGF-β receptor I (TβRI), Smad3 and Mbd2, and erythroid differentiation regulator 1 (Erdr1). TGF-β1 induced fibroblasts to undergo a global DNA hypermethylation along with Mbd2 overexpression in a TβRI/Smad3 dependent manner, and Mbd2 selectively bound to the methylated CpG DNA within the Erdr1 promoter to repress its expression, through which it enhanced TGF-β/Smad signalling to promote differentiation of fibroblast into myofibroblast and exacerbate pulmonary fibrosis. Therefore, enhancing Erdr1 expression strikingly reversed established pulmonary fibrosis. Collectively, our data support that strategies aimed at silencing Mbd2 or increasing Erdr1 could be viable therapeutic approaches for prevention and treatment of pulmonary fibrosis in clinical settings.
引用
- Wang Y, Zhang L, Huang T, et al. The methyl-CpG-binding domain 2 facilitates pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiation. Eur Respir J. 2022. PMID: 35086828. doi:10.1183/13993003.03697-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。